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Objective. To adjust and validate the Global Competency Framework (GbCF) to be relevant for
Croatian community and hospital pharmacists.
Methods. A descriptive study was conducted in three steps: translation, consensus development, and
validation by an expert panel and public consultation. Panel members were representatives from
community pharmacies, hospital pharmacies, regulatory and professional bodies, academia, and
industry.
Results. The adapted framework consists of 96 behavioral statements organized in four clusters:
Pharmaceutical Public Health, Pharmaceutical Care, Organization and Management, and Personal
and Professional Competencies. When mapped against the 100 statements listed in the GbCF, 27
matched, 39 were revised, 30 were introduced, and 24 were excluded from the original framework.
Conclusions. The adaptation and validation proved that GbCF is adaptable to local needs, the
Croatian Competency Framework that emerged from it being an example. Key amendments were
made within Organization and Management and Pharmaceutical Care clusters, demonstrating that
these issues can be country specific.
Keywords: competency, behavioral statement, competency framework, Global Competency Framework,
Croatian Competency Framework
INTRODUCTION
Implementation of pharmacy competencies as a ba-
sic prerequisite for providing pharmaceutical care and
ensuring patient treatment outcomes is increasingly sup-
porting the development of pharmacists across sectors.1,2
Competency pertains to knowledge, skills, attitudes,
and behaviors that affect an individual’s role or respon-
sibilities, relate to job performance, and are subject
to improvement through training and development ac-
tivities.3 Competency-based developmental frameworks
are increasingly common among health professions in
high-income countries and are frequently used to define
standards for education and training and for career pro-
gression.4 They contain a structured assembly of behav-
ioral competencies that can contribute to supporting
practitioner development and allow for effective and sus-
tained performance.
Culture can influence expectations of pharmaceuti-
cal services by public and regulatory bodies, and religion,
traditions, history, experiences, and perceptions of med-
ications all challenge the unified understanding of
competencies in pharmacy.5 Therefore, the International
Pharmacy Federation, through the Pharmacy Education
Initiative (FIPEd) developed an evidenced-based Global
Competency Framework (GbCF), a document that con-
tains a core set of behavioral competencies that should be
generally applicable for the pharmacy workforce world-
wide.6 The GbCF does not imply that there should be
a single global curriculum that would fit all countries,
but rather that it can be taken by other countries and
adapted to their own needs.
Development of a national competency framework
for pharmacists in Croatia was important as it could lay
the foundation for bridging the gap between traditional
pharmacy education and the ever-changing demands of
modern health care systems. One of the major drawbacks
of the Croatian continuing eduaction (CE) model is lack
of a supporting system that could assist pharmacists in
identifying their learning needs and supporting their
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development. Therefore, development of the Croatian
Competency Framework (CCF) for pharmacists, with
minimum competencies required, was a way to resolve
those issues, namely assessing the differences between
the established and desired levels of their performance
and informing development of a competency-based cur-
riculum to achieve the desired level of competency, as
previously conducted on a “pharmaceutical care com-
petencies” cluster.7 Furthermore, strategies for quality
improvement of CE and continuous professional devel-
opment (CPD) educational activities have been offered
and could serve as a complementary supporting system
for continuing education development.8
The Croatian Competency Framework could assist
individuals and organizationswith career planning oppor-
tunities and allow the pharmacy sector to implement use-
ful and harmonized professional development on national
level. Therefore, the aim of this research was to adapt and
validate the GbCF to be relevant for Croatian community
and hospital pharmacists.
METHODS
To develop a competency framework for community
and hospital pharmacists inCroatia, aGbCFdeveloped by
the FIPEd was used.6 A descriptive study was conducted
in three consecutive steps: translation, consensus devel-
opment, and validation by an expert panel and public
consultation. Each subsequent phase was informed by
and built upon the preceding phase.
Following the standard methods of translation, the
original English version of the GbCF was translated into
the Croatian language by expert pharmacists familiar
with terminology of the area covered by the framework
and knowledgeable of English-speaking culture. Based
on the Brislin translationmodel, the frameworkwas then
back-translated by two bilingual translators, both ver-
sions were compared for accuracy and equivalence,
and any discrepancies that had occurred during the
process were negotiated.9 It was further refined by phar-
macists’ perceptions and input from lay readers. The
procedures of translation and back-translation of the
framework did not reveal any changes from the original
(English) version of the instrument, except the contextu-
alization of background information relevant and appli-
cable to the Croatian context.
During the next stage, a consensus development
panel convened consisting of 10 pharmacists with exper-
tise in community practice (n54), hospital pharmacy
(n52), industry (n51), regulatory affairs (n51), and ac-
ademia (n52), who reviewed the list of behavioral state-
ments to adjust the GbCF according to Croatian national
needs. In adapting the GbCF, consideration was given to
the current pharmacy practice at the primary care level in
Croatia to ensure its relevance for pharmacists working in
a community and hospital sector. From the beginning of
the data-reviewing process, an iterative process of 18
rounds of consensus development panels in the period
from February to July 2014 was undertaken to evaluate
and make changes to the initial competency framework.
Each panel session was facilitated by a pharmacist with
expertise in community pharmacy and regulatory poli-
cies, and with knowledge of the GbCF.
The group sessions lasted 180 minutes and were
guided by a moderator who used an interview guide to
probe participants’ perceptions regarding the knowledge
and skills a pharmacist must possess to meet the require-
ments of professional practice at a foundation level. Fol-
lowing the introductory lecture, panel members were
introduced to the GbCF’s development and validation
process, protocol, and structure of the panel sessions. Ob-
jectives that needed to be addressed during the adaptation
process were presented and included the following con-
siderations: whether the language was clear and under-
standable; whether the clustering was correct (ie, whether
the labels assigned to each cluster made sense and if not,
whether they could be rephrased or replaced; whether
there was any competency and/or behavior missing con-
sidering the Croatian setting; and whether there was any
competency and/or behavior not applicable to the Croa-
tian setting.
Panel members were then asked to reach consensus
on each behavioral statement bearing in mind its useful-
ness and applicability, and recommend amendments and
inclusions if necessary. Finally, panel members were
asked to categorize the competencies into clusters. The
panel sessions were audio recorded. Within a week after
a session, member checking was performed by e-mailing
a summary of the discussion to the participants and asking
them to confirm its accuracy.
The draft framework that emerged from the consen-
sus development group was evaluated for content validity
by pharmacists with experience in community pharmacy
(n52), hospital pharmacy (n51), professional body
(n51), regulatory body (n51), and academia (n52). In-
dividuals who participated in the expert panel group did
not attend the consensus development panels.
An iterative process of five rounds of expert panel
groups in the period from July to September 2014 was
undertaken to evaluate and make changes to the compe-
tency framework yielded by the previous group. At the
start of each session, the procedure was explained briefly,
and theoretical saturation was considered to have been
reached when a new session yielded no new information.
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Each revised competency cluster was reviewed to
ensure consistency of terminology and overall content,
and to reevaluate its applicability and usefulness for
general level primary care. Before the first meeting, the
panel members were invited to rank the relevance (on a
5-point Likert scale where 15not relevant and 55very
relevant) and wording of the behaviors and competen-
cies, after which they received written feedback com-
prising the means and standard deviations of the
relevance scores and a summary of the textual com-
ments. They were also asked to edit or reword each state-
ment they felt needed revision and to provide additional
information as appropriate. In the absence of an existing
standard, a strict definition of consensuswas used: a com-
petency had to be rated as relevant (4) or very relevant (5)
by at least 80% of panel members.10 Minor revisions
were made to the wording in response to comments from
panel members.
The amended framework underwent a final review
(fifth session) by an expert panel before distribution to
members of the Croatian Pharmacy Chamber, all regis-
tered pharmacists, for final critique. The final compe-
tency framework resulting from this process was made
available for a public consultation with the aim of col-
lecting comments and suggestions frommembers of the
Croatian Pharmacy Chamber before drafting the final
document. The process consisted of three related forms
of interaction with interested members of the pharmacy
public: notification, consultation, a 2-way flow of in-
formation, using an online survey-tool via the cham-
ber’s website, and participation, an active meeting of
interest groups, held at the University of Zagreb Faculty
of Pharmacy and Biochemistry to increase the sense of
ownership of, or commitment to, the framework beyond
what is likely to be achieved via a purely consultative
approach.
All participants in the consensus development
groups and the expert panel groups gave informed consent
in response to a letter that explicitly stated that participa-
tion was voluntary and that gave assurance of full confi-
dentiality, pursuant to the Croatian “regulations on the
duty of protection of professional and official confidential
information” (IRB number: 330-02-114-10).
RESULTS
The purpose of this study was to adapt and validate
a framework of pharmacy competencies relevant for com-
munity and hospital setting by examining whether phar-
macy experts could reach consensus. In this sample of 17
pharmacists [gender: all female; mean age 42.15 (18.2)
years], overall mean duration of work experience in the
pharmacy setting was 18.15 (9.2) years.
An initial draft of the CCF for pharmacists was de-
veloped from the source framework GbCF and methods
for establishing and developing consensus followed by
public consultation. One hundred behavioral statements,
grouped in four competency clusters, were used for the
review from the GbCF. The mapping of the behavioral
statements from the source document and expert panel
confirmed the importance of these four existing com-
petency clusters, although amendments were necessary
(Table 1).When CCFwasmapped against the 100 behav-
ioral statements listed in the GbCF, 27 could be found in
the adapted framework, 39 were revised, 30 were newly
introduced, and 24 from the original framework were
excluded. A detailed overview of amendments can be
found in Table 2. The scope of the CCF encompasses
foundation-level or early-years practice and represents
national consensus on the capability competencies of
the outcomes of registration levels of initial career edu-
cation and training.
The panel members of the consensus development
group agreed about changing some competency headings,
behavior wording and descriptors for clarification pur-
poses, amalgamation of two competencies into one as to
display the process of working (such as procurement and
the ancillary supply chain management) as intercon-
nected, transfer of a competency from one cluster to an-
other, change of behavioral statement order within the
competency to present the sequence of activities in amore
logical manner, and the change of competency order
within clusters. Some of themost significant amendments
Table 1. A Comparison between the Global Competency Framework (GbCF) and Croatian Competency Framework (CCF) in
Number of Competencies and Behavioral Statements Across Four Clusters
Competency Cluster
No. of Competencies No. of Behavioral Statements
GbCF CCF GbCF CCF
Pharmaceutical Public Health 2 1 4 3
Pharmaceutical Care 6 5 25 36
Organisztion and Management 6 5 32 31
Personal and Professional 6 6 39 26
Total 20 17 100 96
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to the CCF included addition of new competencies (eg,
“Assurance of safe medicines use” in the Pharmaceutical
Care cluster, “Organization” in the Organization and
Management cluster) and exclusion of three competen-
cies (“Medicines information and advice” from the Phar-
maceutical Public Health cluster, “Medicines” and
“Monitor medicines therapy” from the Pharmaceutical
Care competences cluster).
Further amendments encompassed exclusion of
competencies that were too broad or unspecific, immea-
surable (eg, “Recognize the value of the pharmacy team
and of a multidisciplinary team”), not yet present in Cro-
atian pharmacy practice (eg, “Ensure appropriate quality
control tests are performed and managed appropriately in
Quality Assurance and Research in the workplace com-
petency), or too advanced for foundation level framework
(eg, Apply research findings and understand the benefit
risk (eg, preclinical, clinical trials, experimental clinical-
pharmacological research and risk management).
Several statements of similar content (eg, “Identify
if expertise needed outside the scope of knowledge”
and “Identify learning needs”) were replaced for one be-
havioral statement. Additional modifications included
clarifying the “Compoundmedicines” competency by in-
cluding additional behaviors regarding extemporaneous
preparations compounding and storage; combining “Pro-
curement” and “Supply-chain management” competen-
cies and adding behaviors regarding procurement and
supply chain management; adding behaviors relating to
“Patient consultations” competency in the Pharmaceuti-
cal Care cluster; and adding behavior statements regard-
ing human resources and workplace management in the
Organisation and Management cluster.
After the adaptation process, the mean relevance
scores of each behavioral statement and some minor
adjustments of the competencies (eg, wording) were
reached by the expert panel members. A summary of
relevancy mean scores and standard deviations for all be-
havioral statements is detailed in Table 3. Ninety-four
percent (n590) of behavioral statements were rated as
relevant by more than 80% of respondents. During the
validation process, consensus was reached on keeping
the remaining six statements as they were considered rel-
evant for Croatian practice. The “Encourage and conduct
research at the workplace” [3.9 (0.69), N57], “Under-
stand the tendering methods and evaluation of tender
bids” [3.7 (1.11), N57], and “Monitor and report on use
of medicines and medical devices [3.9 (0.69), N57],
showed the least relevance. This may reflect the absence
of workplace research culture. Furthermore, tendering is
a method applicable for hospital pharmacy and a small
proportion of community pharmacies supplying prison
and nursing home facilities and was thus recognized as
important by a lower proportion of pharmacists present in
the expert panel. Moreover, monitoring and reporting on
the use of medications and medical devices is usually
carried out by a community or hospital pharmacy man-
ager and so was not recognized by the remaining phar-
macy personnel as highly important. Nevertheless, these
statements followed the validation process considered
important for foundation level practice, and consensus
was reached on retaining them.
The expert panel agreed to the majority of amend-
ments proposed by the consensus development panel and
further refined the framework in terms of uniformity of
language, wording, and some minor amendments not af-
fecting the content itself, bearing in mind the perspective
and the context of the Croatian pharmacy profession.
After public consultation with all registered pharma-
cists (n53431), only 26 responses were received, all of
which were included in the final draft. Those comments
addressed the issues related to procurement and supply
chainmanagement and patient consultation competencies
clarification, distinctions between hospital and commu-
nity pharmacy dispensing and adverse drug reactions
reporting, and organizing and providing competency-
informed education for registered pharmacists. The big-
gest fear expressed by pharmacists was not being up to
date with knowledge and skills to satisfy the competen-
cies in the competency framework. All pharmacists found
the framework clear and easy to understand and stated
that the framework reflected the core competencies of a
community/hospital pharmacist. Many useful comments
and suggestions were also received from pharmacists on
how the framework could be improved, and pharmacists
provided additional behaviors useful to the framework.
The framework could, therefore, be considered the com-
petency standards set by both the regulatory body and the
profession itself.
Upon consultation with the profession, the frame-
work was updated and finalized to reflect the comments
and suggestions received during the consultation process.
The final framework consisted of 96 behavioral state-
ments, grouped in 17 competencies under four main
competency domains: Pharmaceutical Public Health,
Pharmaceutical Care, Organisation and Management,
and Personal and Professional. A detailed overview of
the framework is given in Table 3.
DISCUSSION
This is the first comprehensive Croatian Compe-
tency Framework eligible for supporting pharmacists
working in community and hospital sector in Croatia.
American Journal of Pharmaceutical Education 2016; 80 (8) Article 134.
9
T
ab
le
3
.
O
v
er
v
ie
w
o
f
th
e
A
d
ap
te
d
C
ro
at
ia
n
C
o
m
p
et
en
cy
F
ra
m
ew
o
rk
an
d
M
ea
n
R
el
ev
an
cy
S
co
re
s
fo
r
E
ac
h
S
ta
te
m
en
t
C
o
m
p
et
en
cy
B
eh
a
v
io
r
S
ta
te
m
en
t
M
ea
n
R
el
ev
a
n
ce
S
co
re
(S
D
)
P
h
ar
m
ac
eu
ti
ca
l
P
u
b
li
c
H
ea
lt
h
H
ea
lt
h
p
ro
m
o
ti
o
n
A
ss
es
s
th
e
p
u
b
li
c
h
ea
lt
h
n
ee
d
s
o
f
a
lo
ca
l
p
o
p
u
la
ti
o
n
4
.1
(0
.7
)
In
it
ia
te
,
o
rg
an
iz
e
an
d
p
ar
ti
ci
p
at
e
in
p
u
b
li
c
h
ea
lt
h
p
ro
je
ct
s
b
as
ed
o
n
lo
ca
l
p
o
p
u
la
ti
o
n
n
ee
d
s
4
.6
(0
.5
)
A
d
v
is
e
p
o
p
u
la
ti
o
n
o
n
h
ea
lt
h
p
re
se
rv
at
io
n
,
d
is
ea
se
p
re
v
en
ti
o
n
,
h
ea
lt
h
y
li
fe
st
y
le
an
d
sa
fe
an
d
ra
ti
o
n
al
u
se
o
f
m
ed
ic
in
es
an
d
d
ev
ic
es
5
.0
(0
.0
)
P
h
ar
m
ac
eu
ti
ca
l
C
ar
e
A
ss
es
sm
en
t
o
f
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
A
p
p
ly
th
e
p
ri
n
ci
p
le
s
o
f
ev
id
en
ce
-b
as
ed
p
h
ar
m
ac
y
(t
o
m
ak
e
so
u
n
d
cl
in
ic
al
d
ec
is
io
n
s)
4
.9
(0
.4
)
A
p
p
ly
g
u
id
el
in
es
an
d
tr
ea
tm
en
t
p
ro
to
co
ls
5
.0
(0
.0
)
A
p
p
ro
p
ri
at
el
y
se
le
ct
m
ed
ic
in
es
an
d
d
ev
ic
es
ac
co
rd
in
g
to
th
e
g
o
v
er
n
m
en
tp
o
li
cy
,d
ru
g
ac
ce
ss
ib
il
it
y
/a
v
ai
la
b
il
it
y
,a
n
d
p
at
ie
n
ta
n
d
h
o
sp
it
al
n
ee
d
s
an
d
fi
n
an
ci
al
ca
p
ab
il
it
ie
s
5
.0
(0
.0
)
A
p
p
ro
p
ri
at
el
y
se
le
ct
m
ed
ic
in
es
an
d
d
ev
ic
es
ac
co
rd
in
g
to
th
e
p
at
ie
n
t
sy
m
p
to
m
s
an
d
d
ia
g
n
o
si
s
4
.9
(0
.4
)
W
h
en
se
le
ct
in
g
,
id
en
ti
fy
,
p
ri
o
ri
ti
se
an
d
ac
t
u
p
o
n
m
ed
ic
in
e-
m
ed
ic
in
e
in
te
ra
ct
io
n
s;
m
ed
ic
in
e-
d
is
ea
se
in
te
ra
ct
io
n
s;
m
ed
ic
in
e-
p
at
ie
n
t
in
te
ra
ct
io
n
s;
m
ed
ic
in
es
-f
o
o
d
in
te
ra
ct
io
n
s
5
.0
(0
.0
)
C
o
m
p
o
u
n
d
in
g
o
f
m
ag
is
tr
al
an
d
g
al
en
ic
p
re
p
ar
at
io
n
s
D
et
er
m
in
e
an
d
en
su
re
th
e
re
q
u
ir
em
en
ts
fo
r
p
re
p
ar
at
io
n
an
d
st
o
ri
n
g
o
f
m
ag
is
tr
al
an
d
g
al
en
ic
p
re
p
ar
at
io
n
s
4
.9
(0
.4
)
C
o
m
p
o
u
n
d
m
ag
is
tr
al
an
d
g
al
en
ic
p
re
p
ar
at
io
n
s
ac
co
rd
in
g
to
p
ro
fe
ss
io
n
al
p
ri
n
ci
p
le
s,
li
te
ra
tu
re
an
d
g
u
id
el
in
es
5
.0
(0
.0
)
C
o
n
fi
rm
th
e
id
en
ti
ty
an
d
q
u
al
it
y
o
f
en
tr
y
/r
aw
m
at
er
ia
ls
4
.6
(0
.5
)
A
sc
er
ta
in
th
e
q
u
al
it
y
o
f
g
al
en
ic
p
re
p
ar
at
io
n
4
.7
(0
.5
)
A
cc
u
ra
te
ly
la
b
el
m
ag
is
tr
al
an
d
g
al
en
ic
p
re
p
ar
at
io
n
s
5
.0
(0
.0
)
A
p
p
ro
p
ri
at
el
y
st
o
re
g
al
en
ic
p
re
p
ar
at
io
n
s
5
.0
(0
.0
)
D
is
p
en
si
n
g
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
E
st
ab
li
sh
ac
cu
ra
cy
an
d
le
g
al
it
y
o
f
p
re
sc
ri
p
ti
o
n
s
an
d
ce
rt
if
ic
at
io
n
s
o
f
m
ed
ic
al
d
ev
ic
es
an
d
v
al
id
at
e
th
em
ap
p
ro
p
ri
at
el
y
4
.7
(0
.5
)
U
n
d
er
st
an
d
d
ia
g
n
o
si
s
an
d
th
er
ap
eu
ti
c
g
o
al
s
4
.7
(0
.5
)
A
cc
u
ra
te
ly
d
is
p
en
se
p
re
sc
ri
b
ed
m
ed
ic
in
es
5
.0
(0
.0
)
A
cc
u
ra
te
ly
d
is
p
en
se
m
ed
ic
al
d
ev
ic
es
b
as
ed
o
n
ce
rt
ifi
ca
ti
o
n
o
f
m
ed
ic
al
d
ev
ic
e
4
.9
(0
.4
)
A
cc
u
ra
te
ly
re
-p
ac
k
ag
e
m
ed
ic
in
es
an
d
/o
r
m
ed
ic
al
d
ev
ic
es
fr
o
m
th
e
o
ri
g
in
al
p
ac
k
ag
in
g
an
d
ac
cu
ra
te
ly
la
b
el
5
.0
(0
.0
)
L
ab
el
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
w
it
h
th
e
re
q
u
ir
ed
,
p
re
ci
se
an
d
co
m
p
re
h
en
si
b
le
in
st
ru
ct
io
n
s
fo
r
p
at
ie
n
ts
o
r
h
ea
lt
h
ca
re
w
o
rk
er
s
in
h
o
sp
it
al
5
.0
(0
.0
)
A
d
v
is
e
p
at
ie
n
ts
/h
ea
lt
h
ca
re
p
ro
fe
ss
io
n
al
s
in
h
o
sp
it
al
o
n
p
ro
p
er
st
o
ra
g
e
co
n
d
it
io
n
s
o
f
th
e
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
5
.0
(0
.0
)
A
d
v
is
e
p
at
ie
n
ts
/h
ea
lt
h
ca
re
p
ro
fe
ss
io
n
al
s
in
h
o
sp
it
al
o
n
p
ro
p
er
d
is
p
o
sa
l
o
f
u
n
u
se
d
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
4
.6
(0
.5
)
R
ep
o
rt
su
sp
ec
te
d
q
u
al
it
y
d
ef
ec
ts
o
f
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
to
th
e
ap
p
ro
p
ri
at
e
au
th
o
ri
ti
es
5
.0
(0
.0
)
P
at
ie
n
t
co
n
su
lt
at
io
n
E
st
ab
li
sh
a
tr
u
st
in
g
an
d
co
ll
ab
o
ra
ti
v
e
re
la
ti
o
n
sh
ip
w
it
h
th
e
p
at
ie
n
t
4
.7
(0
.5
)
O
b
ta
in
an
d
d
o
cu
m
en
t
p
at
ie
n
ts
’
m
ed
ic
al
an
d
so
ci
al
h
is
to
ry
4
.1
(0
.7
)
Id
en
ti
fy
,
p
ri
o
ri
ti
se
an
d
re
so
lv
e
p
at
ie
n
ts
’
p
h
ar
m
ac
eu
ti
ca
l
p
ro
b
le
m
s
4
.7
(0
.5
)
In
tr
o
d
u
ce
p
at
ie
n
t
w
it
h
h
is
p
h
ar
m
ac
eu
ti
ca
l
p
ro
b
le
m
s
an
d
cl
ea
rl
y
st
at
e
al
l
p
o
ss
ib
le
o
p
ti
o
n
s
th
at
co
u
ld
b
e
u
n
d
er
ta
k
en
to
so
lv
e
th
e
p
h
ar
m
ac
eu
ti
ca
l
ca
re
p
ro
b
le
m
s
id
en
ti
fi
ed
.
4
.7
(0
.5
)
A
d
v
is
e
p
at
ie
n
t
o
n
p
ro
p
er
m
ed
ic
in
e
an
d
m
ed
ic
al
d
ev
ic
e
u
se
4
.9
(0
.4
)
A
d
v
is
e
p
at
ie
n
t
o
n
h
ea
lt
h
p
re
se
rv
at
io
n
an
d
h
ea
lt
h
y
li
fe
st
y
le
4
.9
(0
.4
)
C
o
n
ta
ct
o
r
re
fe
r
ap
p
ro
p
ri
at
el
y
to
th
e
m
ed
ic
al
d
o
ct
o
r
4
.9
(0
.4
)
E
x
p
la
in
w
h
at
to
d
o
an
d
w
h
o
m
to
co
n
ta
ct
in
ca
se
o
f
a
n
ew
th
er
ap
eu
ti
c
p
ro
b
le
m
4
.7
(0
.5
)
D
o
cu
m
en
t
an
y
in
te
rv
en
ti
o
n
4
.7
(0
.5
)
E
n
su
re
th
er
ap
eu
ti
c
m
o
n
it
o
ri
n
g
o
f
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
4
.6
(0
.8
)
(C
o
n
ti
n
u
ed
)
American Journal of Pharmaceutical Education 2016; 80 (8) Article 134.
10
T
ab
le
3
.
(C
o
n
ti
n
u
ed
)
C
o
m
p
et
en
cy
B
eh
a
v
io
r
S
ta
te
m
en
t
M
ea
n
R
el
ev
a
n
ce
S
co
re
(S
D
)
A
ss
u
ra
n
ce
o
f
sa
fe
m
ed
ic
in
es
u
se
N
o
te
,
p
re
v
en
t
an
d
ac
t
u
p
o
n
m
ed
ic
at
io
n
er
ro
rs
5
.0
(0
.0
)
D
o
cu
m
en
t
m
ed
ic
at
io
n
er
ro
rs
in
in
te
rn
al
m
ed
ic
at
io
n
er
ro
r
re
p
o
rt
in
g
sy
st
em
s
4
.3
(0
.8
)
R
eg
u
la
rl
y
re
p
o
rt
m
ed
ic
at
io
n
er
ro
rs
to
in
te
rn
al
C
o
m
m
it
te
es
/a
p
p
ro
p
ri
at
e
au
th
o
ri
ti
es
,
if
p
o
ss
ib
le
4
.2
(0
.8
)
R
eg
u
la
rl
y
m
o
n
it
o
r
an
d
b
e
u
p
to
d
at
e
w
it
h
m
ed
ic
at
io
n
er
ro
r
re
p
o
rt
s
4
.6
(0
.5
)
R
ec
o
g
n
iz
e
an
d
re
p
o
rt
ad
v
er
se
d
ru
g
re
ac
ti
o
n
s
to
th
e
ap
p
ro
p
ri
at
e
au
th
o
ri
ti
es
5
.0
(0
.0
)
B
e
u
p
to
d
at
e
w
it
h
th
e
ac
tu
al
in
fo
rm
at
io
n
re
la
te
d
to
m
ed
ic
at
io
n
sa
fe
ty
4
.9
(0
.4
)
O
rg
an
iz
at
io
n
an
d
M
an
ag
em
en
t
O
rg
an
iz
at
io
n
D
em
o
n
st
ra
te
k
n
o
w
le
d
g
e
o
f
th
e
o
rg
an
iz
at
io
n
al
st
ru
ct
u
re
o
f
co
m
m
u
n
it
y
p
h
ar
m
ac
y
/i
n
st
it
u
ti
o
n
4
.2
(0
.8
)
D
em
o
n
st
ra
te
k
n
o
w
le
d
g
e
o
f
th
e
re
la
ti
o
n
sh
ip
b
et
w
ee
n
co
m
m
u
n
it
y
p
h
ar
m
ac
y
/i
n
st
it
u
ti
o
n
an
d
o
th
er
st
ak
eh
o
ld
er
s
4
.4
(0
.8
)
A
d
h
er
e
to
n
at
io
n
al
d
ir
ec
ti
v
es
an
d
g
u
id
el
in
es
in
re
la
ti
o
n
sh
ip
w
it
h
st
ak
eh
o
ld
er
s
4
.0
(1
.0
)
F
in
an
ce
m
an
ag
em
en
t
U
n
d
er
st
an
d
an
d
ad
h
er
e
to
th
e
fi
n
an
ci
al
p
la
n
o
f
co
m
m
u
n
it
y
p
h
ar
m
ac
y
/i
n
st
it
u
ti
o
n
4
.6
(0
.5
)
P
ro
p
er
ly
in
v
o
ic
e
an
d
ch
ar
g
e
d
is
p
en
se
d
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
an
d
en
su
re
th
e
p
ro
p
er
d
o
cu
m
en
ta
ti
o
n
4
.7
(0
.5
)
E
n
su
re
th
e
ab
il
it
y
to
m
o
n
it
o
r
th
e
co
n
d
u
ct
o
f
fi
n
an
ci
al
tr
an
sa
ct
io
n
s
4
.9
(0
.4
)
M
o
n
it
o
r
an
d
re
p
o
rt
o
n
u
se
o
f
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
3
.9
(0
.7
)
H
um
an
re
so
ur
ce
s
m
an
ag
em
en
t
A
ss
ig
n
ta
sk
s
to
em
p
lo
y
ee
s
(e
ac
h
m
em
b
er
o
f
th
e
st
af
f)
w
it
h
in
th
e
sc
o
p
e
o
f
th
ei
r
jo
b
d
es
cr
ip
ti
o
n
4
.6
(0
.8
)
M
o
n
it
o
r
w
o
rk
o
f
em
p
lo
y
ee
s
an
d
ev
al
u
at
e
th
ei
r
co
m
p
et
en
cy
4
.4
(0
.5
)
R
ec
o
g
n
iz
e
th
e
n
ee
d
s
an
d
p
o
te
n
ti
al
o
f
ea
ch
m
em
b
er
o
f
th
e
st
af
f
an
d
en
ab
le
th
ei
r
p
er
so
n
al
an
d
p
ro
fe
ss
io
n
al
d
ev
el
o
p
m
en
t
4
.7
(0
.5
)
E
n
co
u
ra
g
e
em
p
lo
y
ee
s’
se
lf
-c
o
n
sc
ie
n
ce
an
d
th
ei
r
p
ro
fe
ss
io
n
af
fi
li
at
io
n
4
.6
(0
.5
)
W
or
kp
la
ce
m
an
ag
em
en
t
A
d
d
re
ss
an
d
m
an
ag
e
d
ay
to
d
ay
m
an
ag
em
en
t
is
su
es
4
.7
(0
.8
)
E
n
su
re
th
e
w
o
rk
ti
m
e
is
ap
p
ro
p
ri
at
el
y
p
la
n
n
ed
an
d
m
an
ag
ed
ac
co
rd
in
g
to
d
ir
ec
ti
v
es
,
in
te
rn
al
d
ec
is
io
n
s
an
d
n
ee
d
s
o
f
th
e
w
o
rk
4
.6
(0
.8
)
E
n
co
u
ra
g
e
p
o
si
ti
v
e
w
o
rk
in
g
at
m
o
sp
h
er
e,
o
p
en
co
m
m
u
n
ic
at
io
n
an
d
co
ll
ab
o
ra
ti
o
n
w
it
h
in
th
e
w
o
rk
in
g
en
v
ir
o
n
m
en
t
4
.6
(0
.8
)
E
n
co
u
ra
g
e
p
o
si
ti
v
e
w
o
rk
in
g
at
m
o
sp
h
er
e,
o
p
en
co
m
m
u
n
ic
at
io
n
an
d
co
ll
ab
o
ra
ti
o
n
w
it
h
o
th
er
h
ea
lt
h
ca
re
p
ro
fe
ss
io
n
al
s
4
.7
(0
.5
)
E
n
su
re
ad
h
er
en
ce
to
th
e
ru
le
s
o
f
G
o
o
d
p
h
ar
m
ac
y
p
ra
ct
ic
e
5
.0
(0
.0
)
S
y
st
em
at
ic
al
ly
tr
an
sf
er
et
h
ic
al
an
d
m
o
ra
l
v
al
u
es
to
em
p
lo
y
ee
s
an
d
le
ad
b
y
ex
am
p
le
4
.9
(0
.4
)
P
ro
cu
re
m
en
t
an
d
su
p
p
ly
ch
ai
n
m
an
ag
em
en
t
F
o
ll
o
w
an
d
b
e
u
p
to
d
at
e
w
it
h
th
e
n
ew
s
o
n
d
ru
g
m
ar
k
et
an
d
re
ly
o
n
re
li
ab
le
in
fo
rm
at
io
n
n
ec
es
sa
ry
fo
r
th
e
p
ro
cu
re
m
en
t
p
ro
ce
ss
4
.9
(0
.4
)
E
n
su
re
th
e
m
o
st
co
st
-e
ff
ec
ti
v
e
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
in
th
e
ri
g
h
t
q
u
an
ti
ti
es
b
as
ed
o
n
av
ai
la
b
il
it
y
o
f
th
e
d
ru
g
m
ar
k
et
5
.0
(0
.0
)
D
ev
el
o
p
an
d
im
p
le
m
en
t
co
n
ti
n
g
en
cy
p
la
n
fo
r
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
sh
o
rt
ag
es
4
.6
(0
.5
)
O
rg
an
is
e
p
ro
cu
re
m
en
t
in
li
n
e
w
it
h
co
n
tr
ac
ts
an
d
p
ay
m
en
t
ca
p
ab
il
it
ie
s
4
.3
(0
.8
)
O
rg
an
iz
e
re
li
ab
le
p
ro
cu
re
m
en
t
o
f
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
in
a
ti
m
el
y
m
an
n
er
4
.7
(0
.8
)
A
p
p
ly
th
e
co
rr
ec
t
p
ro
ce
d
u
re
o
f
in
te
rv
en
ti
o
n
im
p
o
rt
5
.0
(0
.0
)
E
n
su
re
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
ar
e
o
f
ap
p
ro
p
ri
at
e
q
u
al
it
y
,
w
it
h
in
ex
p
ir
y
d
at
e
an
d
ar
e
n
o
t
co
u
n
te
rf
ei
t
4
.9
(0
.4
)
A
sc
er
ta
in
th
e
ac
cu
ra
cy
o
f
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
d
el
iv
er
y
4
.7
(0
.5
)
E
n
su
re
st
o
ra
g
e
o
f
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
in
a
co
rr
ec
tl
y
m
an
n
er
4
.7
(0
.5
)
E
n
su
re
ac
cu
ra
te
p
ro
ce
d
u
re
s
o
f
re
tu
rn
o
f
m
ed
ic
in
es
an
d
m
ed
ic
al
d
ev
ic
es
4
.4
(0
.8
)
E
n
su
re
p
ro
p
er
d
o
cu
m
en
ta
ti
o
n
an
d
re
co
rd
k
ee
p
in
g
4
.7
(0
.5
)
F
o
rm
p
ri
ce
s
in
li
n
e
w
it
h
p
ro
ce
d
u
re
s
an
d
in
st
it
u
ti
o
n
p
o
li
cy
4
.6
(0
.8
)
E
n
su
re
ap
p
ro
p
ri
at
e
ca
te
g
o
ry
m
an
ag
em
en
t
in
li
n
e
w
it
h
co
m
m
u
n
it
y
p
h
ar
m
ac
y
/i
n
st
it
u
ti
o
n
p
o
li
cy
4
.0
(0
.8
)
U
n
d
er
st
an
d
th
e
te
n
d
er
in
g
m
et
h
o
d
s
an
d
ev
al
u
at
io
n
o
f
te
n
d
er
b
id
s
3
.7
(0
.1
)
(C
o
n
ti
n
u
ed
)
American Journal of Pharmaceutical Education 2016; 80 (8) Article 134.
11
T
ab
le
3
.
(C
o
n
ti
n
u
ed
)
C
o
m
p
et
en
cy
B
eh
a
v
io
r
S
ta
te
m
en
t
M
ea
n
R
el
ev
a
n
ce
S
co
re
(S
D
)
P
er
so
n
al
an
d
P
ro
fe
ss
io
n
al
C
om
m
un
ic
at
io
n
sk
il
ls
C
o
m
m
u
n
ic
at
e
cl
ea
rl
y
,
p
re
ci
se
ly
,
o
b
je
ct
iv
el
y
an
d
ap
p
ro
p
ri
at
el
y
4
.9
(0
.4
)
D
em
o
n
st
ra
te
cu
lt
u
ra
l
an
d
so
ci
al
aw
ar
en
es
s
an
d
se
n
si
ti
v
it
y
4
.9
(0
.4
)
D
em
o
n
st
ra
te
n
eg
o
ti
at
in
g
sk
il
ls
in
th
e
ev
en
t
o
f
p
ro
b
le
m
s
an
d
co
n
fl
ic
ts
4
.3
(0
.8
)
C
o
n
ti
n
u
in
g
P
ro
fe
ss
io
n
al
D
ev
el
o
p
m
en
t
(C
P
D
)
E
v
al
u
at
e
cu
rr
en
cy
o
f
k
n
o
w
le
d
g
e
an
d
sk
il
ls
an
d
id
en
ti
fy
le
ar
n
in
g
an
d
p
ro
fe
ss
io
n
al
d
ev
el
o
p
m
en
t
n
ee
d
s
4
.7
(0
.5
)
C
o
n
ti
n
u
o
u
sl
y
d
ev
el
o
p
to
an
sw
er
th
e
id
en
ti
fi
ed
le
ar
n
in
g
g
ap
s
4
.7
(0
.5
)
E
v
al
u
at
e
o
w
n
w
o
rk
in
g
p
er
fo
rm
an
ce
4
.6
(0
.5
)
E
x
ch
an
g
e
an
d
tr
an
sf
er
p
ro
fe
ss
io
n
al
k
n
o
w
le
d
g
e
4
.7
(0
.5
)
D
o
cu
m
en
t
C
P
D
ac
ti
v
it
ie
s
4
.4
(0
.5
)
L
eg
al
an
d
re
g
u
la
to
ry
p
ra
ct
ic
e
U
n
d
er
st
an
d
an
d
ap
p
ly
h
ea
lt
h
ca
re
an
d
p
h
ar
m
ac
eu
ti
ca
l
ac
ti
v
it
y
le
g
is
la
ti
o
n
,
an
d
fo
ll
o
w
am
en
d
m
en
ts
4
.6
(0
.5
)
D
em
o
n
st
ra
te
k
n
o
w
le
d
g
e
o
f
th
e
fu
n
d
am
en
ta
ls
o
f
le
g
is
la
ti
o
n
in
fi
n
an
ci
al
m
an
ag
em
en
t
an
d
in
te
ll
ec
tu
al
p
ro
p
er
ty
ri
g
h
ts
4
.0
(0
.8
)
D
em
o
n
st
ra
te
k
n
o
w
le
d
g
e
an
d
ap
p
ly
le
g
is
la
ti
o
n
re
la
te
d
to
d
ru
g
s
w
it
h
th
e
p
o
te
n
ti
al
fo
r
ab
u
se
,
an
d
fo
ll
o
w
am
en
d
m
en
ts
4
.6
(0
.8
)
D
em
o
n
st
ra
te
k
n
o
w
le
d
g
e
an
d
ap
p
ly
fu
n
d
am
en
ta
ls
o
f
le
g
is
la
ti
o
n
in
m
ar
k
et
in
g
,
ad
v
er
ti
si
n
g
an
d
sa
le
s
4
.1
(0
.7
)
D
em
o
n
st
ra
te
k
n
o
w
le
d
g
e
o
f
la
b
o
u
r
le
g
is
la
ti
o
n
4
.4
(0
.5
)
P
ro
fe
ss
io
n
al
an
d
et
h
ic
al
p
ra
ct
ic
e
A
ct
in
li
n
e
w
it
h
C
o
d
e
o
f
E
th
ic
s
an
d
d
eo
n
to
lo
g
y
an
d
G
o
o
d
p
h
ar
m
ac
y
p
ra
ct
ic
e
5
.0
(0
.0
)
E
n
su
re
co
n
fi
d
en
ti
al
it
y
o
f
p
at
ie
n
t’
s
p
er
so
n
al
d
at
a
4
.9
(0
.4
)
O
b
ta
in
p
at
ie
n
t
co
n
se
n
t,
w
h
en
n
ec
es
sa
ry
4
.7
(0
.5
)
T
ak
e
re
sp
o
n
si
b
il
it
y
fo
r
o
w
n
ac
ti
o
n
an
d
fo
r
p
at
ie
n
t
ca
re
4
.9
(0
.4
)
Im
p
ro
v
em
en
t
o
f
se
rv
ic
e
an
d
q
u
al
it
y
as
su
ra
n
ce
M
o
n
it
o
r
th
e
q
u
al
it
y
o
f
p
h
ar
m
ac
y
se
rv
ic
es
4
.7
(0
.5
)
Im
p
ro
v
e
cu
rr
en
t
an
d
in
tr
o
d
u
ce
n
ew
se
rv
ic
es
4
.6
(0
.5
)
D
ev
el
o
p
,
im
p
le
m
en
t
an
d
co
n
d
u
ct
S
ta
n
d
in
g
O
p
er
at
in
g
P
ro
ce
d
u
re
s
(S
O
P
’s
)
4
.7
(0
.5
)
E
n
co
u
ra
g
e
an
d
co
n
d
u
ct
re
se
ar
ch
at
th
e
w
o
rk
p
la
ce
3
.9
(0
.7
)
D
o
cu
m
en
t
an
d
ta
k
e
ca
re
o
f
u
n
w
an
te
d
o
cc
u
rr
en
ce
s
at
th
e
w
o
rk
p
la
ce
an
d
in
fo
rm
th
e
in
te
rn
al
d
ep
ar
tm
en
t/
b
o
d
y
o
f
co
m
m
u
n
it
y
p
h
ar
m
ac
y
/i
n
st
it
u
ti
o
n
th
er
eo
f.
4
.6
(0
.5
)
L
ea
rn
fr
o
m
p
re
v
io
u
s
u
n
w
an
te
d
o
cc
u
rr
en
ce
s
an
d
p
re
v
en
t
fu
rt
h
er
o
n
es
4
.7
(0
.5
)
P
er
so
n
al
d
ev
el
o
p
m
en
t
E
v
al
u
at
e
an
d
d
ev
el
o
p
se
lf
-c
o
n
fi
d
en
ce
an
d
se
lf
-c
o
n
sc
io
u
sn
es
s
4
.4
(0
.8
)
D
em
o
n
st
ra
te
in
te
re
st
,
in
it
ia
ti
v
e
an
d
in
n
o
v
at
io
n
4
.4
(0
.8
)
D
em
o
n
st
ra
te
ti
m
e-
m
an
ag
em
en
t
sk
il
ls
4
.4
(0
.8
)
American Journal of Pharmaceutical Education 2016; 80 (8) Article 134.
12
The adapted framework reflects the current status of phar-
macy practice in Croatia and lays foundation for the new
pharmacy contract with Croatian Health Insurance Fund
regarding the provision of advanced services. Moreover,
Croatia is among the first non-English speaking countries
in Southeastern Europe to have used, properly adjusted,
and validated the global framework, adapting it to its
national needs. The assessment of Croatian community
pharmacists’ patient care competencies using the General
Level Framework was previously investigated and pro-
vided a foundation for the enforcement of the current
study.11 Other countries from the region that are develop-
ing competency frameworks include Serbia,12 Slov-
enia,13 and Monte Negro, whereas Lithuania and
Turkey have recently started with implementation. The
CCF employed methodology similar to the one used by
Ireland, the first country to have adapted the GbCF, with
the exception of translation and cross-cultural adapta-
tion.14 Both frameworks, although similar in structure,
yielded two dissimilar documents.
Croatia has a different pharmacy practice tradition
compared to Anglo-Saxon countries that already use
competency frameworks in various health care sectors
and are consequently more accustomed to it.15-22 Con-
cepts of pharmaceutical care and clinical pharmacy,
namely patient-centred practices are underdeveloped
and lack inclusion in the nation’s health care system. In
addition, competencies per se are a part of educational
paradigm which is not yet fully implemented in our edu-
cational system and much effort was invested to dissem-
inate information regarding its relevance and educate
pharmacy public on the matter. The process is not com-
pleted and time is needed for the concept to be compre-
hended and accepted by Croatian pharmacists.
Despite the fact that the adaptation of a culturally
different GbCF presented quite a challenge, we strongly
believe that the process could serve as an example to other
European countries with similar pharmacy practice-
related issues that have not yet developed their own
country-specific framework. We found that although
there were barriers in the process of creating the na-
tional competency framework, they could be overcome
by taking into account standard methods of translation
and cross-cultural adaptation.23-26 Furthermore, we con-
firmed that the methodology used in this process could
yield a country-specific framework that we recommend to
other countries.
When comparing GbCF and CCF, most differences
are in the Pharmaceutical Care and Organization and
Management competency clusters. Although consider-
able congruence was noticed between the original and
adapted document in Pharmaceutical Care, additional be-
haviors were needed. The framework was primarily mod-
ified within the Patient Consultation competency, which
grew to 10 from the original six statements. For years,
Pharmaceutical Care remained unrecognized and unprac-
ticed along with its key patient-centered skill, patient
consultation, and pharmacists weremerely advice-givers.
In the light of changes and acknowledged necessity for
pharmaceutical care development, as well as the impor-
tance of the consultation skills as a 2-way process, authors
considered it essential to disassemble this composite pro-
cess to consecutive steps and add more behaviors as to
familiarize pharmacists with the sequence of activities
within the Patient Consultation cluster.
The most amended cluster was Organization and
Management, where approximately half of the competen-
cies were replaced and the other half were revised. This
highlights the importance of adapting the generic global
competency framework in organizational andmanagerial
issues to the local and national circumstances, as these can
be country-specific. Although pharmaceutical care is
a universal practice not necessarily related to culture,
tradition, and history, it differs from country to country
depending on the level of its development.
As for statements that represent the future pharma-
cists’ roles but are not yet incorporated in the health
care system (eg, reporting document medication errors
in internal medication error reporting systems; report-
ing medication errors to internal committees/appropriate
authorities), most were retained with an aim of raising
awareness about them, especially when using the frame-
work in the undergraduate context.
Following public consultation, a low response rate
was obtained, as expected, reflecting pharmacists’ poor
engagement, initiative, and interest in competencies and
their implementation. Unfortunately, this is a result of the
lack of understanding of the concept and importance of
competencies by the pharmacy profession. However, an
unexpectedly high proportion of pharmacists (N598) an-
swered the invitation and participated in the closing event,
reporting that they wanted to contribute to the final draft.
This demonstrated a slow, but existent, shift in pharma-
cists’ perceptions and assisted in forming a new climate in
Croatian community and hospital setting.
The adapted framework was created following an
evidence-based approach and was validated by an expert
and individual pharmacists’ opinion. The pharmacists
working across various pharmacy sectors received an of-
ficial invitation for participation in the project from the
Croatian Pharmacy Chamber, and had subsequently been
recruited. A pragmatic approach to recruitment was adop-
ted because of the high level of commitment required of
participants over a long period of time. Within the study
American Journal of Pharmaceutical Education 2016; 80 (8) Article 134.
13
period, 23 session rounds (workshops with an average
duration of 180 minutes) were organized, suggesting
a high level of enthusiasm and support. All participating
pharmacists continued their involvement in the project
throughout the one-year period as they were eager to con-
tribute to the development of the framework, which con-
firmed the need for a competency framework.
The adapted framework will inform the curriculum
development, serve as a basis for pharmacists’ training in
community and hospital setting, provide a foundation for
a newCPDmodel, and offer support for workforce devel-
opment. The CCF will be tested among student popula-
tions during their 6-month preregistration period and
among practicing pharmacists, duringwhich their clinical
activities will prospectively be recorded at several time
points. Twomethods of students’ competency assessment
will be employed: self-assessment by students at two
time-points (following six weeks and six months) and
vertical assessment conducted on behalf of students’
mentors/preceptors at the end of the preregistration train-
ing to evaluate student performance. The evaluation of the
CCF will demonstrate whether the adapted framework
sustains pharmacists’ development and is efficient at de-
veloping the competence of students in community and
hospital pharmacy towards a registered pharmacist. Fol-
lowing the initial implementation of the framework, au-
thors intend to continue refining and validating the
framework in regard to ambiguities, inapplicability, or
lack of clarity of certain behaviors.
Further research is needed to determine whether the
methodology applied in our study can serve as amodel for
adapting and developing other countries’ frameworks,
especially in the countries with similar pharmacy practice
policy, and whether the CCF can role-model and inform
that development.
We instigated this research as the profession needs
a systematic and standardized platform to demonstrate
to other health care professionals, patients, and pharma-
cists the role we play in the safe and responsible pharma-
ceutical care provision. By actively incorporating quality
improvement through competency-based framework,
pharmacists can bring about systematic changes about
how patient care is delivered.
The current study was limited in several ways. First,
the selection of the expert panelmembers and the question
of sample representativeness was raised, especially when
considering that all participants were female. However,
consensus panel methodology typically utilizes non-
random sampling because of the need for expert iden-
tification; in fact, literature consistently supports the
use of selected panelists.27,28 Additionally, based on the
data from Croatian Chamber of Pharmacists, gender
distribution is predominantly female (93%). Further is-
sues included: panel members not being a representative
population, which makes the findings difficult to general-
ize; participants having subjective views that may have
fluctuated over time; and group dynamics potentially
restricting some panel members from voicing their opin-
ions. To minimize those limitations, the facilitator
attempted to enable a balanced discursive contribution
among panel members. Another limitation was that the
CCF is specifically tailored to the country’s current phar-
macy practice situation.
Considering the changing environment of pharmacy
practice, we recommend an ongoing process of compe-
tency framework evaluation and validation to ensure its
sustained value in the future. Finally, an issue on equal
competency comprehension by all pharmacists was
raised. Indeed, without the description of each behavioral
statement, one could not be certain that all pharmacists
comprehended the listed competencies and the pertaining
behaviors in the same manner, even with the provided
explanation in a form of a handbook.
CONCLUSION
This adaptation and validation demonstrated that
a global framework can be adaptable to local needs, as
the Croatian Competency Framework emerged from the
GbCF, and can be used for creating a country-specific
mapping tool. Key amendments were made in the Orga-
nization andManagement and Pharmaceutical Care com-
petencies clusters, demonstrating that these issues can be
country-specific.
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